EMMLF - OKYO Pharma Limited reports FY results August, 02 2021 07:29 AM OKYO Pharma Corp OKYO Pharma Limited (OTCQB:EMMLF): FY Total comprehensive loss of £2,99M Cash balance at 31 March 2021 of £4,99M vs. £190k a year ago. Press Release For further details see: OKYO Pharma Limited reports FY results